ID 405459542 · FY 2022–2024 · 3 years
კომპანიის ძირითადი საქმიანობის სფეროა საბითუმო ვაჭრობა ფარმაცევტული საქონლით 2.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2022 | 2023 | 2024 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 15.6% | 10.1% | 29.2% |
| EBITDA Margin | 10.8% | 1.9% | 27.3% |
| EBITDAR | 1,032 | 167 | 1,760 |
| EBITDAR Margin | 10.8% | 1.9% | 27.3% |
| EBIT Margin | 10.6% | 1.7% | 27.0% |
| Net Profit Margin | 11.9% | 3.7% | 26.1% |
| Operating Expense % of Sales | 4.8% | 8.2% | 1.9% |
| Returns | |||
| Return on Assets (ROA) | 44.6% | 11.3% | 40.0% |
| Return on Equity (ROE) | 207.6% | 89.9% | 95.9% |
| ROIC [EBIT / Invested Capital] | 117.1% | 17.6% | 77.0% |
| Leverage & liquidity | |||
| Debt-to-Assets | 42.7% | 37.5% | 33.4% |
| Debt-to-Equity | 1.99x | 3.00x | 0.80x |
| Debt-to-EBITDA | 1.05x | 6.56x | 0.80x |
| Equity-to-Assets | 21.5% | 12.5% | 41.7% |
| Net Debt | 318 | 478 | 507 |
| Cash & Equivalents | 769 | 617 | 896 |
| Total Debt | 1,087 | 1,094 | 1,402 |
| Efficiency & working capital | |||
| Inventory Turnover | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A |
| Receivables Turnover | 30.26x | 12.03x | 6.43x |
| Days Sales Outstanding (DSO) | 12.1 | 30.3 | 56.8 |
| Payables Turnover | 8.95x | 5.51x | 4.38x |
| Days Payable Outstanding (DPO) | 40.8 | 66.2 | 83.4 |
| Cash Conversion Cycle | -28.7 days | -35.9 days | -26.6 days |
| Asset Turnover | 3.75x | 3.06x | 1.53x |
| Cash flow & dividends | |||
| Operating Cash Flow | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).